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para-Hydroxy benzoic acid (PHBA) is the key component for preparing parabens, 
a common preservatives in food, drugs, and personal care products, as well as 
 high-performance bioplastics such as liquid crystal polymers. Pseudomonas putida 
KT2440 was engineered to produce PHBA from glucose via the shikimate pathway inter-
mediate chorismate. To obtain the PHBA production strain, chorismate lyase UbiC from 
Escherichia coli and a feedback resistant 3-deoxy-d-arabino-heptulosonate-7-phos-
phate synthase encoded by gene aroGD146N were overexpressed individually and simul-
taneously. In addition, genes related to product degradation (pobA) or competing for the 
precursor chorismate (pheA and trpE) were deleted from the genome. To further improve 
PHBA production, the glucose metabolism repressor hexR was knocked out in order to 
increase erythrose 4-phosphate and NADPH supply. The best strain achieved a maxi-
mum titer of 1.73 g L−1 and a carbon yield of 18.1% (C-mol C-mol−1) in a non-optimized 
fed-batch fermentation. This is to date the highest PHBA concentration produced by 
P. putida using a chorismate lyase.
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inTrODUcTiOn
The aromatic hydroxy acid, para-Hydroxy benzoic acid (PHBA) is commonly used in the chemical 
industry. It is a key component in the manufacturing of liquid crystal polymers (LCP) with high-
value applications in the thermoplastics market (Ibeh, 2011). PHBA is also used to prepare paraben 
preservatives in the cosmetics, food, and pharmaceutical industries. Current production of PHBA is 
based on petroleum-derived chemicals through the Kolbe–Schmitt reaction. However, the reaction’s 
requirements for high-temperature/high-pressure conditions, along with the problem of by-product 
formation (Yoshida and Nagasawa, 2007), make the production of this aromatic compound relatively 
expensive. The volatility of raw material prices and decreasing availability in the future, together 
with environmental concerns are driving the development of a renewable and sustainable process 
for PHBA production (Erickson et al., 2012; Gavrilescu, 2014).
Microbial production of chemicals from renewable resources is a sustainable alternative and the 
bio-production pathways for aromatics and aromatic derivatives have been intensively studied for 
FigUre 1 | Production of aromatic compounds via shikimate pathway in microbes. Red framed box indicates central metabolism, and green framed box 
indicates shikimate pathway. Compounds have industrial interest are highlighted in red color. Dashed arrows indicate multi-enzymatic synthesis. DHQ, 
3-dehydroquinate; DHS, 3-dehydroshikimate; SHIK, shikimate; S3P, shikimate-3-phosphate; EPSP, 5-enolpyruvyl-shikimate 3-phosphate; CHA, chorismate; HPP, 
4-hydroxy phenyl pyruvate; ANAT, anthranilate; PPA, prephenate; PPY, phenyl pyruvate; 4ABA, 4-aminobenzoic acid; SAA, salvianic acid A; 4HCA, p-hydroxy 
cinnamic acids; PLA, phenyl lactic acid; 4HPLA, 4-hydroxy phenyl lactic acid; 2-PE, phenyl ethanol; PAA, phenyl acetic acid; 4HPAA, 4-hydroxy phenyl acetic acid; 
2,3-CHD, S,S-2,3-dihydroxy-2,3-dihydrobenzoic acid; 3,4-CHD S,S-3,4-dihydroxy-3,4-dihydrobenzoic acid; aroZ, 3-DHS dehydratase; aroY, PCA decarboxylase; 
catA, catechol 1,2-dioxygenase; feaB, phenylacetaldehyde dehydrogenase; tpl, Tyr phenol lyase from Pantoea agglomerans; tyrDC, tyramine decarboxylase gene 
from Lactobacillus brevis; pdc, 4HCA decarboxylase from L. plantarum; tyrB, tyrosine aminotransferase; hpaBC, an endogenous hydroxylase from E. coli; ldh, lactate 
dehydrogenase from L. pentosus; pal, Phe-ammonia lyase/Tyr-ammonia lyase from Rhodosporidium toruloides; kivD, phenylpyruvate decarboxylase tyrA, biofunctional 
chorismate mutase/prephenate dehydrogenase; entB, isochorismatase; entC, isochorismate synthase; melA, tyrosinase; fcs, p-coumaroyl-CoA synthetase; ech, 
p-coumaroyl-CoA hydratase/lyase; vdh, p-hydroxybenzaldehyde dehydrogenase; ipl, isochorismate pyruvate lyase; SMO, salicylate 1-monoxygenase; pheA, 
bifunctional chorismate mutase/prephenate dehydratase; tal, tyrosine ammonia lyase; Coum3H, 4-coumarate hydroxylase; ubiC, chorismate.
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the past decades (Wierckx et al., 2005; Verhoef et al., 2007; Weber 
et al., 2012; Krömer et al., 2013; Lin et al., 2014; Averesch et al., 
2016). The shikimate pathway is the key pathway for the synthesis 
of the aromatic amino acids l-tryptophan (Trp),  l-phenylalanine 
(Phe), and l-tyrosine (Tyr), the synthesis of quinones, folates, 
secondary metabolites, and derived compounds including many 
commercially valuable compounds (Figure  1) (Gosset, 2009; 
Karpf and Trussardi, 2009; Koma et  al., 2012; Curran et  al., 
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2013; Zhang and Stephanopoulos, 2013). The pathway links 
carbohydrate metabolism to aromatic compound biosynthesis 
by converting phosphoenolpyruvate (PEP) and d-erythrose 
4-phosphate (E4P) from the central carbon metabolism into 
3-deoxy-d-arabino-heptulosonate-7-phosphate (DAHP), after a 
sequence of seven reactions chorismate, a universal precursor for 
aromatic amino acids and other aromatic compounds, is formed 
(Bentley, 1990). Microbial production of PHBA has been studied 
in engineered strains of Escherichia coli (Barker and Frost, 2001), 
Klebsiella pneumoniae (Müller et al., 1995), and in Saccharomyces 
cerevisiae (Krömer et al., 2013; Williams et al., 2015). Barker and 
colleagues further engineered E. coli l-tryptophan-producing 
strain D2704 by inserting extra copies of genes from shikimate 
pathway, aroA (5-enolpyruvylshikimate 3-phosphate synthase), 
aroL (shikimate kinase), aroB (3-dehydroquinate synthase), 
and aroF (feedback-insensitive DAHP synthase) as well as 
overexpressed ubiC (chorismate lyase) and tktA (transketolase), 
achieved a titer of 12 g L−1 and a C-mole yield of 13%. Further 
increase of the yield was unattainable due to the toxic effect this 
concentration of PHBA has on E. coli. Additionally, a significant 
amount by-product formation was observed in the fermenta-
tion and the introduction of many unbalanced genes may lead 
to metabolic burdens resulting in an undesired fermentation 
performance.
Pseudomonas putida is well known for its versatile metabo-
lism, fast growth rate with simple nutrient requirement, high 
robustness against harsh environmental conditions, and low 
cellular maintenance demand. Moreover, P. putida has a natural 
high resistance to PHBA. Few or no by-product formation such 
as acetate, glycerol, or ethanol which are frequently observed 
in industrial production host E. coli, Bacillus subtilis, and 
S. cerevisiae (Ebert et  al., 2011; Poblete-Castro et  al., 2012). 
Furthermore, P. putida almost exclusively use Entner–Doudoroff 
pathway (ED pathway) enabling it generates more NADPH 
which is important for maximization product titer (Ng et  al., 
2015) and prevention oxidative stress (Chavarría et al., 2013). 
The production of shikimate pathway-derived chemicals will 
benefit from higher NADPH regeneration rate as the conver-
sion of 3-dehydroshikimate into shikimate needs NADPH as 
the cofactor. All these features not only endow it as a flexible 
cell factory for bulk chemicals production but also highlight this 
strain as a promising workhorse for toxic chemicals production. 
A number of examples demonstrate its great potential in the 
production of a wide range chemicals, especially toxic aromat-
ics such as phenol (Wierckx et al., 2005), PHBA (Verhoef et al., 
2007), 4-hydroxy styrene (Verhoef et al., 2009), 3-nitrocatechol 
(Prakash et al., 2010), and 4-hydroxy quinaldine (Ütkür et al., 
2011). But it is also a suitable host for the production of more 
traditional bio-products such as poly-hydroxy alkanoates (Le 
Meur et al., 2012).
Metabolic engineering of P. putida for the production of 
PHBA was first described in strain S12palB1, this strain was 
able to produce a maximum titer of 12.9  mM PHBA with a 
C-mole yield of 8.5% on glycerol in a carbon-limited fed-batch 
fermentation (Verhoef et al., 2007). Yields were further increased 
by a mixed-substrate feeding strategy (Meijnen et al., 2011). This 
PHBA production strain was metabolically engineered based on 
the coumarate pathway (tyrosine degradation, Figure 1), which 
has a lower theoretical yield than production of PHBA using the 
chorismate lyase (UbiC) (Krömer et al., 2013). In addition, fur-
ther improvement of this strain was difficult as the platform strain 
was based on random nitrosoguanidine (NTG) mutagenesis, and 
the unknown genetic basis limits strain improvement.
Here, we present the production of PHBA from glucose using 
the more efficient chorismate lyase route in P. putida KT2440 
using rational engineering. Increased PHBA production was 
achieved through genetic deletion of PHBA degrading pathways 
as well as pathways competing for chorismate. In addition to 
overexpression of ubiC, a feedback-resistant DAHP synthase 
encoded by aroGD146N was also overexpressed. Finally, we explored 
the effect of deletion of the gene encoding for glucose metabolism 
repressor hexR and its effect on PHBA production.
MaTerials anD MeThODs
Bacterial strains and Plasmids
Bacterial strains and plasmids used in this study are listed in 
Table 1. P. putida KT2440 (DSMZ 6125) was used as production 
host, and E. coli XL10-Gold (Agilent Technologies Inc.) was 
used to prepare all plasmids except the R6K plasmids which 
were prepared in E. coli DH5α λpir (Martinez-Garcia and de 
Lorenzo, 2011).
chemicals and reagents
All chemicals are of analytical purity, purchased from Sigma-
Aldrich (Australia) or Chem-Supply (Australia). Yeast extract 
and tryptone were purchased from Merck and Oxoid (Australia). 
Restriction enzymes, T4 ligase, and DNA polymerase were 
purchased from New England Biolabs (Australia) and were used 
according to the supplier’s recommendation. Plasmid isolations 
or DNA fragment purifications were done using GeneJET kits 
for Plasmid Miniprep, Gel Extraction, or the PCR Purification 
(Thermo Fisher Scientific Australia Pty. Ltd.).
Media
Lysogeny broth (LB) consisted of 10 g L−1 tryptone, 5 g L−1 yeast 
extract, and 5 g L−1 sodium chloride (Lennox, 1955) and was used 
to culture E. coli and P. putida strains. Antibiotics of the final con-
centration of 50 μg mL−1 kanamycin or 50 μg mL−1 gentamycin 
were added into medium when it was needed. To make solid 
plates, 1.5–1.7% (w/v) agar was added into the medium.
Fully chemically defined media were used in shake flask and 
bioreactor experiments with the following composition: chemi-
cally defined medium (CDM) for flask cultivation contained per 
liter: 6 g Na2HPO4, 3 g KH2PO4, 2 g NH4Cl, and 0.2 g MgSO4⋅7H2O 
and 15 mg CaCl2⋅2H2O, and 1 mL trace element solution (1.5 g L−1 
FeCl3⋅6H2O, 0.15 g L−1 H3BO3, 0.03 g L−1 CuSO4⋅5H2O, 0.18 g L−1 
KI, 0.12 g L−1 MnCl2⋅4H2O, 0.06 g L−1 Na2MoO4⋅2H2O, 0.023g L−1 
NiCl2⋅6H2O, 0.12 g L−1 ZnSO4⋅7H2O, 0.15 g L−1 CoCl2⋅6H2O, and 
10  g  L−1 EDTA). This medium was supplemented with 5  g  L−1 
glucose as sole carbon source, 50  μg  mL−1 kanamycin (where 
appropriate), 0.5 mmol L−1 Trp, and 0.5 mmol L−1 phenyl pyru-
vate (PPY).
TaBle 1 | The strains and plasmids used in this study.
characteristics reference
Plasmids
pSEVA234 Silva-Rocha et al. (2013)
pSEVA234-ubiC kmR, expression vector containing the gene of ubiC This study
pSEVA234-UA kmR, expression vector containing the gene of ubiC and the gene aroGD146N mutant DAHP synthase This study
pEMG Martinez-Garcia and de Lorenzo (2011)
pEMG-pobATS1TS2 kmR, using for pobA gene deletion from genome This study
pEMG-pheATS1TS2 kmR, using for pheA gene deletion from genome This study
pEMG-trpETS1TS2 kmR, using for trpE gene deletion from genome This study
pEMG-hexRTS1TS2 kmR, using for hexR gene deletion from genome This study
stains’ name
E. coli XL10-Gold endA1 glnV44 recA1 thi-1 gyrA96 relA1 lac Hte Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 tetR 
F΄[proAB lacIqZΔM15 Tn10(TetR Amy CmR)]
Stratagene/agilent technologies
E. coli DH5α λpir endA1 hsdR17 glnV44 (=supE44) thi-1 recA1 gyrA96 relA1 φ80dlacΔ(lacZ)M15 Δ(lacZYA-argF)U169 
zdg-232::Tn10 uidA::pir+
Martinez-Garcia and de Lorenzo (2011)
S0 Pseudomonas putida KT2440 DSM 6125, wild type DSMZ
S1 The stain S0 knockout the gene pobA and overexpress gene ubiC This study
S2 S2 derived from strain S1 by the further deletion of pheA, overexpress gene ubiC This study
S3 S3 derived from strain S2 by the further deletion of trpE, overexpress gene ubiC This study
S4 S4 derived from strain S3 by the further deletion of hexR, overexpress gene ubiC This study
S5 S5 derived from strain S3 by the overexpression of ubiC and aroGD146N This study
S6 S6 derived from strain S4 by the overexpression of ubiC and aroGD146N This study
KmR, kanamycin resistance.
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Based on Sun’s protocol two different media were used 
for the seed culture and the fermentation in bioreactor 
experiments (Sun et  al., 2006). Inoculum was prepared in 
seed medium containing the following components per liter: 
4.7 g (NH4)2SO4, 0.24 g MgSO4⋅7H2O, 6.35 g Na2HPO4, 2.7 g 
KH2PO4, 9.0  g glucose, 15  mg CaCl2⋅2H2O, 0.75  g tryptone, 
0.3 g NaCl and 0.15 g yeast extract, 1 mL trace metal solution, 
0.5 mmol Trp and 1 mmol PPY, and 50 mg−1 kanamycin. CDM 
was modified for bioreactor initial fermentation containing per 
liter: 4.7  g (NH4)2SO4, 0.24  g MgSO4⋅7H2O, 9.53  g Na2HPO4, 
4.05  g KH2PO4, 1  g glucose, 15  mg CaCl2⋅2H2O, 1  mL trace 
metal solution, 0.5 mmol Trp, and 1 mmol PPY. Feed solution 
contained per liter: 600  g glucose, 6  g MgSO4⋅7H2O, 150  mg 
CaCl2⋅2H2O, 10 mmol Trp, 100 mg kanamycin, and 10 mL trace 
metal solution. Phenylpyruvate was fed by syringe based on 
0.307 mmol PPY gCDW−1. The PPY demand was calculated based 
on the abundance of Phe and Tyr in the E. coli biomass com-
position (Pramanik and Keasling, 1997), since both bacteria 
belongs to Gammaproteobacteria.
cultivation conditions
All shake flask incubation was carried out in baffled Erlenmeyer 
flasks in an incubator (2.5 cm orbit, Multitron, Infors, Bottmingen, 
Switzerland) at 200 rpm. Incubation temperature for flasks and 
plates was 37°C for E. coli and 30°C for P. putida.
To select best performing strain, the PHBA production 
strains were first cultivated for 8 h in 5 mL LB. Fifty microliters 
of this culture was inoculated into a fresh 25-mL CDM medium 
overnight, and the next day was inoculated to 35-mL CDM 
medium in a 250-mL baffled flask to the initial OD600 of 0.2. 
The inducer isopropyl β-d-1-thiogalactopyranoside (IPTG) was 
added to a final concentration of 1  mmol  L−1 when the OD600 
reached 0.3–0.4. Two additional feeds to the final concentration 
of 0.5 mM PPY and 5 g L−1 glucose were added at 6 and 20 h, 
respectively. Samples were centrifuged (16,000 g, 10 min, room 
temperature) and supernatants were stored in the freezer (−20°C) 
for further analysis.
Fed-batch fermentations with P. putida were carried out in 
two 1.0  L working volume Biostat B+ bioreactors (Sartorius, 
Germany), with initial volumes of 0.4 L. Temperature was set at 
30 ± 0.5°C and pH was automatically controlled at 7.0 ± 0.1 using 
14–15% (w/v) NH4OH, which also served as additional nitrogen 
source for cell growth. Dissolved oxygen (DO) was maintained 
at a minimum of 40% through automatic control of the agitation 
between 500 and 2000 rpm followed by variation of air flow from 
0.15 to 1.5 L min−1. Seed cultures were grown in seed medium 
at 30°C, 200 rpm flasks overnight (around 13–16 h), collected in 
mid-exponential phase and then inoculated into the fermenter 
with initial OD600 of 1.0 ± 0.1. The inducer IPTG was added in the 
early exponential phase (3–4 h), with an initial concentration of 
2.5 mM. The feed phase was started half an hour after inoculation 
(Figure S3 in Supplementary Material). The antifoam polypro-
pylene glycol P2000 (Sigma-Aldrich, Australia) was added when 
onset of foaming was observed.
Dna Manipulation
Gene Deletions (ΔpobA, ΔpheA, ΔtrpE, and ΔhexR)
Gene deletions were performed in P. putida following a multi-
ple, seamless, and marker-less genomic editing method from 
Martinez-Garcia and de Lorenzo (2011). The resulting strains are 
listed in Table 1, and gene knockout process or overexpression 
is shown in Figure S1 in Supplementary Material. Primers used 
in this study are listed in Table S2 in Supplementary Material. 
The pEMG-based knockout plasmids were constructed using a 
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standard restriction and ligation approach. To ease the construc-
tions, the nested fusion PCR approach was applied to increase 
PCR amplification specificity (Figure S1A in Supplementary 
Material). Briefly, the fusion gene fragments and pEMG vector 
were digested with BamHI/EcoRI, ligated with a T4 DNA ligase, 
and transformed into chemical competent cells (E. coli DH5α 
λpir). The positive transformants were obtained from blue–white 
screening, and further verified with colony PCR, restriction 
digestion, and sequencing (performed by Australian Genome 
Research Facility Ltd.), resulting in the four knockout plasmids 
pEMG-ΔpobA, pEMG-ΔpheA, pEMG-ΔtrpE, and pEMG-ΔhexR. 
The plasmids were electro-transformed into P. putida-competent 
cells according to Choi’s protocol (Choi and Schweizer, 2006). 
The resulting strains were transformed with the plasmid express-
ing ISce-I endonuclease (pSW-2) for cutting the pEMG vector 
backbone (Figure S1B in Supplementary Material). Then, the 
strains were induced with 15 mM 3-methylbenzoate for 6–8 h, 
and spread on LB plates containing 50  μg  mL−1 gentamycin. 
Finally, selected mutant strains were confirmed using colony 
PCR with primers of P2/P5. The desired mutant should have 
the expected size of around 1000 bp (Table S2 in Supplementary 
Material). Auxotrophic mutants were also verified on solid CDM 
medium plate, 5  g  L−1 glucose with and without 0.5  mM Trp, 
and/or 0.5 mM Phe and 0.5 mM Tyr supplementation (the dele-
tion of gene trpE generated the tryptophan auxotroph, and the 
deletion of gene pheA yielded tyrosine and phenylalanine double 
auxotrophic mutants).
expression Plasmid construction
The genes ubiC encoding chorismate lyase from E. coli K-12 
substr. W3110 (CAA40681.1) and aroGD146N encoding feedback 
insensitive DAHP synthase (Kikuchi et  al., 1997) were codon 
optimized and synthesized by Integrated DNA Technologies, 
Inc. These two genes were digested with EcoRI, SalI, and HindIII, 
respectively, then inserted into the vector pSEVA234 (Silva-
Rocha et  al., 2013), resulting in the plasmids pSEVA234-ubiC 
and pSEVA234-UA (Figure S2C in Supplementary Material). The 
sequencing-verified plasmids were electro-transformed into each 
of the knockout mutant P. putida strains.
sodium Dodecyl sulfate Polyacrylamide 
gel electrophoresis
Culture samples for sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) were collected by centrifugation 
(16,000 g, 5 min, and room temperature). Pellets were washed with 
buffer once and resuspended with 50 mM Tris–HCl buffer (pH 
7.5). Cells were then disrupted using sonication for 5–10 cycles 
of 10 s pulse with 10 s interval on ice to prepare protein extracts. 
For preparation of whole-cell protein samples, the loading buffer 
was added directly to the crude lysate. For the analysis of soluble 
protein expression, the cell lysate was first centrifuged at 16,000 g 
for 20 min at 4°C to remove cell debris and insoluble particles. 
Then, the loading buffer containing β-mercaptoethanol and SDS 
was added, and heated (5 min, 95–99°C) to denature the protein. 
SDS-PAGE was performed using 12% polyacrylamide gel accord-
ing to Laemmli’s protocol (Laemmli, 1970) in a vertical slab gel 
apparatus from Bio-Rad Laboratories. Coomassie brilliant blue 
G-250 was used for gel staining.
analytical Methods
Pseudomonas putida cell densities were monitored by a spectro-
photometry (GENESYS 10S UV–Vis, USA) at the wavelength of 
600 nm (OD600) against water. The correlation between OD and 
cell dry weight (CDW) was empirically determined to be CDW 
(g L−1) = 0.486 OD600. Sugars, organic acids (Lai et al., 2016a), 
and aromatic compounds (Lai et al., 2016b) were measured by 
high-performance liquid chromatography (HPLC). Carbon 
dioxide was monitored by gas analyzer (Balzers Thermostar GSD 
300 T3, Liechtenstein). Carbon balance calculation was follow-
ing the equation of F(C, in) = F(C, out) ≈ F(C, sugars) + F(C, 
organic acids) + F(C, aromatics) + F(C, CO2) + F (C, biomass). 
Specifically, carbon composition in P. putida KT2440 biomass is 
48.8% (W W−1) (van Duuren et al., 2013).
resUlTs anD DiscUssiOn
Metabolic engineering of PhBa 
Production strains
There is a solid body of research for the metabolic engineering of 
shikimate pathway-derived aromatics, mainly using E. coli and 
Corynebacterium glutamicum. P. putida strain development for 
the production of PHBA can be built on this knowledge and apply 
successful genetic engineering strategies. Knockout targets were 
chosen based on their ability to degrade PHBA or to compete 
with the enzyme responsible for PHBA production (UbiC) for 
precursor availability. Compared to E. coli and C. glutamicum, 
more unique to P. putida strains is the ability for aromatics deg-
radation and the multitude of degradation pathways for different 
aromatics (Jiménez et al., 2002). To increase PHBA concentra-
tion, the genes pobA, pheA, trpE, and hexR were deleted from 
the genome of P. putida KT2440 using the pEMG/pSW-2 system 
(Martinez-Garcia and de Lorenzo, 2011). The pobA gene encodes 
p-hydroxy benzoate hydroxylase and causes product degradation. 
The gene pheA encodes the bifunctional enzyme of prephenate 
dehydratase and chorismate mutase, this will direct carbon flux 
into the tyrosine and phenylalanine synthesis, and is a major 
competitor for the precursor chorismate. The disruption of trpE, 
which encodes anthranilate synthase component I, is likely to 
reduce the drain of chorismate into the tryptophan biosynthesis. 
As a consequence, the deletion of pheA and trpE was carried out 
to increase precursor supply to PHBA production by blocking the 
branching of the flux toward the synthesis of the aromatic amino 
acids (Figure 2). Both deletions resulted in aromatic amino acids 
auxotrophic mutants, but when depleted would cause the natural 
feedback inhibition of the shikimate pathway to be alleviated. It is 
also important to note that Pseudomonas species can degrade Phe 
and Tyr through the homogentisate pathway, which can cause a 
difficulty to screen Δphe mutant and the inconvenience in fed-
batch fermentation. Phe is first converted into Tyr by the action 
of the gene products of phhAB phenylalanine hydroxylase, which 
are regulated by the PhhR regulator protein in the presence of 
the two amino acids (Herrera and Ramos, 2007). They are then 
FigUre 2 | schematic view of metabolic engineering in P. putida for PhBa production. AroGD146N, feedback resistant DAHP synthase; E4P, erythrose 
4-phosphate; HPP, 4-hydroxyphenyl pyruvate; PEP, phosphoenolpyruvate; ANAT, anthranilate; PheA, chorismate mutase/prephenate dehydratase; PhhAB, 
phenylalanine hydroxylase; PPA, prephenate; PPY, phenylpyruvate; PobA, p-hydroxy benzoate hydroxylase; TrpE, anthranilate synthase component I; UbiC, 
chorismate lyase; HexR, repressor for glucose metabolism.
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further degraded via the homogentisate degradation pathway, 
and metabolites are channeled to the tricarboxylic acid (TCA) 
cycle (Arias-Barrau et al., 2004). Glucose metabolism repressor 
hexR controls glucokinase (glu), glyceraldehyde-3-phosphate 
(gap-1), and several Entner–Doudoroff pathway enzymes (zwf, 
pgl, edd, and eda), the deletion of this repressor may increase 
the flux toward pentose phosphate pathway (PPP) and NADPH 
pool. The deletion of hexR was expected to increase availability 
of shikimate pathway precursors E4P and the necessary reducing 
equivalents NADPH (Figure 2). Successful deletants were chosen 
based on LB screening with the appropriate antibiotic selection as 
described in Section “Materials and Methods.”
Chorismate lyase encoded by ubiC is a key enzyme in PHBA 
synthesis; it specifically hydrolyzes chorismate into the products 
PHBA and pyruvate. The ubiC gene from E. coli K-12 strain 
was cloned into vector pSEVA234 regulated with Ptrc/LacIq. 
E. coli wild-type UbiC enzyme was shown to be insoluble when 
overexpressed in E. coli, protein manipulations made to increase 
solubility resulted in some loss of enzyme activity (Stover et al., 
2000; Holden et  al., 2002). To optimize expression of soluble 
UbiC, different culture temperature (25 and 30°C) and induction 
time (6 and 8 h) were performed. However, unlike previous work 
in E. coli, we did not observe protein precipitation in P. putida 
in any of the tested conditions. Instead, over 90% of E. coli wild 
type UbiC was present in soluble form in P. putida KT2440 using 
culture condition as described above (Figure S2 and Table S1 in 
Supplementary Material).
Finally, to further improve the production of PHBA in P. putida, 
the gene encoding the feedback insensitive 3-deoxy-d-arabino-
heptulosonate 7-phosphate (DAHP) synthase isoenzyme mutant 
AroGD146N (Kikuchi et  al., 1997) was constructed in the same 
operon with UbiC, regulated by the Ptrc/LacIq system (Figure 
S1C in Supplementary Material). This caused an unregulated 
influx of carbon into the shikimate pathway.
On a side note, it was earlier postulated by Kuepper et  al. 
(2015) after screening more than a thousand colonies for pheA 
knockout mutants on complex medium that the presence of the 
homogentisate degradation pathway might hamper the positive 
identification of positive colonies and the addition of precursor 
PPY in minimal medium was helpful to screen for this mutant 
(Kuepper et al., 2015). We successfully identified pheA mutants 
on rich medium when looking for tiny colonies that could be 
easily overlooked amongst the big colonies that did not contain 
the knockout.
FigUre 3 | Various P. putida KT2440 mutant strains for PhBa 
production in shake flask. All mutants were grown in CDM medium 
supplemented with 5 g L−1 glucose and phenyl pyruvate and tryptophan as 
described above. Two additional feeds of 5 g L−1 glucose and 0.5 mM PPY 
were added after 6 and 20 h, respectively. All data were from triplicate 
biological repeats at the late stationary time point of 44 h. Genotypes for 
mutants tested in this study. S1, KTΔpobA/234-ubiC; S2, 
KTΔpobApheA/234-ubiC; S3, KTΔpobApheAΔtrpE/234-ubiC; S4, 
KTΔpobApheAΔtrpEΔhexR/234-ubiC; S5, KTΔpobApheAΔtrpE/234-ubiC-
aroGD146N; and S6, KTΔpobApheAΔtrpEΔhexR/234-ubiC-aroGD146N.
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evaluation of the PhBa Production  
strains in shake Flasks
The performance of the genetically engineered strains 
described above (S1–S6, Table  1) was evaluated for PHBA 
production in shake flasks, showing a maximum yield of 
1.30 ± 0.01 mmolPHBA gCDW−1, a titer of 4.96 ± 0.146 mM, and 
7% (C-mol  C-mol−1) (Figure  3). The single knockout strain 
containing the over expression plasmid of ubiC (strain S1) pro-
duced 0.23 mM PHBA with a yield of 0.075 mmolPHBA gCDW−1. 
An increase of around fivefold in titer and yield was achieved 
with the deletion of chorismate precursor competing genes pheA 
(strain S2). Compared to S1, this was further increased to 12- and 
16-fold increase in titer and yield, respectively, by the deletion of 
the second precursor competing gene trpE (strain S3). Overall, 
indicating a positive effect when deleting precursor competing 
genes. The knockout of hexR in the S3 background did not lead 
to a very large increase in yield and titer (strain S4) nor did the 
overexpression of the feedback resistant DAHP synthase (strain 
S5). However, when combining the knockout of hexR with over-
expression of DAHP synthase (strain S6) a remarkable increase 
of 22- and 17-fold increase in titer and yield was achieved relative 
to the base strain. Compared to S3, S4 has no significant increase 
in yield and titer, and it can be explained by the fact that our 
limited feeding of phenylpruvate and tryptophan alleviated or 
diminished feedback inhibition to their native DAHP synthase 
in P. putida. Unexpectedly, compared to S3, the hexR knockout 
has no substantial improvement for PHBA production but 
the hexR knockout strain combined overexpression of DAHP 
synthase, has a significant improvement in titer and yield. The 
possible reason that the native DAHP synthase was not strong 
enough to drain flux from central metabolism, interestingly, the 
combination of both genetic manipulations can synergistically 
drain the flux from central metabolism to shikimate pathway 
for the PHBA production, leading to a  significant improvement 
either in titer or in yield. The reason for the increase could be that 
Pseudomonas, like many bacteria, features an imbalanced supply 
of PEP and erythrose 4-phosphate (E4P), and increasing PPP 
flux was demonstrated to increase aromatic production in sev-
eral bacteria including P. putida (Chassagnole et al., 2002; Fuhrer 
et al., 2005; Nikel et al., 2015). The general strategies to increase 
the E4P supply are to express genes from PP pathway such as 
tktA encoding transketolase and/or tal encoding transaldolase 
(Lu and Liao, 1997; Ikeda and Katsumata, 1999). The role of 
the hexR protein as a transcriptional repressor of zwf encoding 
the committing step into PPP was described in P. putida and 
its deletion led to increased flux of PPP and reduction of the 
NADP+ pool (del Castillo et al., 2008; Meijnen et al., 2012). In 
our study, titer increased significantly in the S6 strain, likely due 
to an increased precursor supply for our PHBA production from 
glucose.
PhBa Production by Fed-Batch 
Fermentation
The best PHBA producing strain (S6) was selected from the flask 
experiment to evaluate its potential in a fed-batch fermentation. 
P. putida will quickly degrade the provided aromatic amino acids 
Phe and Tyr in fermentation due to the homogentisate degrada-
tion pathway. This would lead to growth arrest in our ΔpheA 
strains, or the need for a constant feed of those amino acids. 
Instead of feeding the two amino acids, we fed the precursor PPY. 
This feed did not stop degradation through the homogentisate 
pathway completely but slowed down the process. We assumed 
P. putida KT2440 has a similar biomass composition to E. coli, 
since both species are γ-proteobacteria (Blank et al., 2008) and 
calculated the necessary PPY feed based on the demand for 
Tyr and Phe. Glucose concentration was 1 g L−1 at the start of 
the fermentation and was fed as described above after inocula-
tion. PPY solution was fed with 0.307 mmol gCDW−1 based on 
the actual cell density at several intervals (5, 8, 10, 15, 20, and 
25 h). Biomass kept growing after OD600 reached ~12 and 6.05 g 
CDW were obtained after 32  h. Fermentation was stopped 
when the working volume of the reactor was reached. Due to 
the volume change in the fed-batch the following section will 
discuss absolute amounts. The carbon balance closed at 100.6% 
meaning that all carbon could be accounted for. As the major 
by-products, α-keto-gluconate was accumulated (545  mmol) 
and CO2 was released (177 mmol) and about half the fed glu-
cose (~765 mmol) remained unused. This was due to the fact 
that glucose was not limiting in the fed-batch but PPY instead. 
P. putida will oxidize glucose in periplasm to gluconate and then 
to α-keto-gluconate. In future experiments, the feed regime 
should be optimized. Nevertheless, PHBA accumulated over 
time and reached a maximum titer of 12.46 mmol (12.5 mM at 
the end of fermentation), and a yield of 2.6 mmol PHBA gCDW−1 
(Figure 4). The product on substrate yield of PHBA based on 
the consumed C6 molecules and PPY (excluding extracellular 
glucose and α-keto-gluconate, which were not taken up by 
the cells), reached 18.1% (C-mol  C-mol−1). Smaller amounts 
FigUre 4 | Profile of mutant strain KTΔpobAΔpheAΔtrpEΔhexR/234Ua in phenyl pyruvate limited fed-batch fermentation in a controlled reactor.  
, biomass, gCDW L−1; , biomass (gCDW); , PHBA (mmol); , PHBA yield (mmol gCDW−1); , consumed glucose (mmol); , CO2 (mmol); , KGA, 
keto-gluconate (mmol); , GA, gluconate (mmol); , acetate (mmol). Insert is showing the yield coefficient (slope of dashed line = 2.6 mmolPHBA gCDW−1).
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of pyruvate, lactate, and succinate could also be observed to 
accumulate throughout the fermentation (data not shown). 
The only other major by-product was acetate at 13 mmol which 
accumulated in the first 20  h and was consumed thereafter 
(Figure  4). This might indicate a redirection of intracellular 
fluxes around the 20-h mark, but this remains to be studied in 
more detail.
In summary, the fed-batch process was able to achieve higher 
carbon yields than the shake flask experiments, but the feeding 
still requires optimization. Compared to published results we 
achieved a similar titer but a higher yield 18.1% (C-mol C-mol−1). 
P. putida S12palB1 (8.5 C-mol C-mol−1) was engineered based on 
the coumarate pathway and had optimized carbon flux toward 
l-tyrosine (Verhoef et  al., 2007), and P.  putida S12pal_xylB7 
(16.3 C-mol C-mol−1) used an optimized mixed-substrate feeding 
strategy and also the coumarate pathway (Meijnen et al., 2011). 
While the experimentally observed yields are not yet approaching 
the calculated theoretical yields of the pathways (Krömer et al., 
2013), this might still indicate that the UbiC based route has a 
higher potential for biotechnological production of PHBA.
cOnclUsiOn
Pseudomonas putida strains show high potential for industrial 
aromatic production, mainly due to their high tolerance toward 
toxic aromatics and the reduced formation of by-products. In this 
paper, we described P. putida production of PHBA from glucose as 
sole carbon source via the chorismate lyase from E. coli, which has 
a higher theoretical yield than the previously described coumarate 
pathway. The mutant strain KTΔpobAΔpheAΔtrpEΔhexR/234UA 
achieved a maximum titer of 12.5  mM in a PPY limited fed-
batch fermentation. This was achieved using a stable, scar-less, 
and marker-less deletion method, to meet industrial application 
requirements. This study lays the basis for using P. putida as a 
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PHBA production host. Further metabolic engineering strategies 
can be applied to enhance production, for example, balancing 
the precursors PEP and E4P or increasing the availability of the 
reducing equivalent NADPH.
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